Skip to content
Search

Latest Stories

NHS Scotland’s 'free' paracetamol costs taxpayers £8.53 per pack

Scottish taxpayers foot £27mn bill for 'free' paracetamol and painkillers
paracetamol (getyimages)

A staggering £27 million of taxpayers’ money wasted every year on free prescriptions for paracetamol and other painkillers - analysis reveals

Scottish Conservative MSP Stephen Kerr has slammed the SNP government for making taxpayers cover the cost of 'free' prescriptions for basic painkillers like paracetamol and ibuprofen on the NHS.

An analysis conducted by Kerr, first reported in The Telegraph, revealed that the NHS Scotland pays as much as £8.53 per pack of paracetamol under its free prescription policy.


Public Health Scotland data shows that nearly 2.5 million prescriptions for the common painkiller were issued in 2023-24, costing more than £14 million.

Including an estimated £7 million to cover the pharmacy “dispensing fee”, the total cost equates to £8.53 per prescription.

In contrast, paracetamol can be purchased for as little as 37p in supermarkets.

Similarly, Kerr’s analysis found that ibuprofen—available over the counter for just 39p—cost the NHS £6.87 per prescription.

Kerr condemned the costs as “beyond absurd,” accusing the SNP of financial mismanagement.

“The SNP Scottish government’s ideological fixation on so-called ‘free’ prescriptions for everyone is an insult to common sense and responsible governance,” Kerr said, as quoted by The Times.

According to Kerr, every year Scottish taxpayers are forced to foot the bill for 3.5 million prescriptions for basic painkillers, resulting in a waste of a staggering £27 million.

“It is beyond absurd that NHS Scotland is paying £8.50 for paracetamol and nearly £7 for ibuprofen when these medications can be bought in supermarkets for mere pennies,” he stated.

Kerr described the situation as “a glaring example of the SNP’s reckless mismanagement and bloated bureaucracy,” where wasteful spending supersedes frontline patient care.

“This isn’t just inefficiency — it’s outright negligence,” he added.

Scotland’s free prescription policy, introduced by SNP ministers in 2011, is estimated to cost the government £1.5 billion in 2022-23.

As part of efforts to cut costs, Caroline Lamb, chief executive of NHS Scotland, wrote to all health boards last summer, urging them to review spending on medicines of “low or limited clinical value.”

She warned of a spending gap of up to £600 million for the current financial year, adding: “This is simply not an acceptable level and risks not only the [health] portfolio failing to balance the financial position, but the wider Scottish government.”

However, Scottish public health minister Jenni Minto defended the policy, arguing that “the prescribing of items such as paracetamol cannot be directly compared with medicines bought in retail outlets due to the limited quantity that can be purchased for the treatment of self-limiting illness or conditions.”

She explained that most people prescribed paracetamol use it to manage chronic pain, and that alternative treatments can be more expensive and may cause more harm through an increased risk of side effects.

Minto affirmed that the Scottish government would continue to protect the free prescription policy.

In England, nine out of 10 prescriptions are free of charge. Prescriptions are also free in Northern Ireland and Wales.

Dangers of taking paracetamol 

Health experts have issued a warning to the public after a study found that regular use of paracetamol could increase the risk of certain life-threatening diseases in some individuals.

A 2022 study revealed that paracetamol raises blood pressure, a key risk factor for heart attacks and strokes.

The research showed that just two weeks of paracetamol use can increase blood pressure in people with hypertension (high blood pressure).

Researchers suggest that this rise in blood pressure could elevate the risk of heart disease or stroke by about 20 per cent.

They recommend that patients with long-term prescriptions for the painkiller should be given the lowest effective dose for the shortest possible duration.

Professor James Dear, chair of Clinical Pharmacology at the University of Edinburgh, highlighted that doctors and patients should together consider ‘the risks versus the benefits’ particularly for those at risk of cardiovascular issues.

However, people who use paracetamol occasionally “shouldn't worry”, said lead investigator Dr Iain MacIntyre, consultant in clinical pharmacology and nephrology at NHS Lothian.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less